0001127602-14-030566.txt : 20141030 0001127602-14-030566.hdr.sgml : 20141030 20141030170745 ACCESSION NUMBER: 0001127602-14-030566 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141030 FILED AS OF DATE: 20141030 DATE AS OF CHANGE: 20141030 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SENSIENT TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000310142 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 390561070 STATE OF INCORPORATION: WI FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 EAST WISCONSIN AVENUE CITY: MILWAUKEE STATE: WI ZIP: 53202 BUSINESS PHONE: 4142716755 MAIL ADDRESS: STREET 1: PO BOX 737 CITY: MILWAUKEE STATE: WI ZIP: 53201 FORMER COMPANY: FORMER CONFORMED NAME: UNIVERSAL FOODS CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CLYDESDALE FERGUS M CENTRAL INDEX KEY: 0001200339 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07626 FILM NUMBER: 141183962 MAIL ADDRESS: STREET 1: 777 E WISCONSIN AVE CITY: MILWAUKEE STATE: WI ZIP: 53202 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2014-10-30 0000310142 SENSIENT TECHNOLOGIES CORP SXT 0001200339 CLYDESDALE FERGUS M 777 EAST WISCONSIN AVENUE MILWAUKEE WI 53202 1 Common Stock 2014-10-30 4 M 0 2000 20.07 A 21443.943 D Common Stock 2014-10-30 4 S 0 2000 57.365 D 19443.943 D Stock Options (Right to Buy) 20.07 2014-10-30 4 M 0 2000 0 D 2006-05-02 2015-05-02 Common Stock 2000 0 D Stock Options (Right to Buy) 20.25 2007-05-01 2016-05-01 Common Stock 2000 2000 D Stock Options (Right to Buy) 26.12 2008-05-01 2017-05-01 Common Stock 2000 2000 D Stock Options (Right to Buy) 30.07 2009-05-01 2018-05-01 Common Stock 2000 2000 D Exercise of in-the-money stock option that would otherwise expire on 5/2/2015, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e). Includes shares of restricted stock held under Issuer's 2002 Non-Employee Director Stock Plan and 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan. This amount represents the weighted average sale price for the transactions reported on this line. The actual sale prices ranged from $57.33 to $57.40. The reporting person hereby agrees to provide, upon request by the SEC staff, by the Issuer, or by any security holder of the Issuer, full information regarding the number of shares sold at each separate price Original option grant vests in three equal annual installments beginning on the date listed in the "Date Exercisable" column. /s/ John L. Hammond, Attorney-in-Fact for Dr. Clydesdale 2014-10-30